profit from every $100 of sales.
$0$100
Cross Country Healthcare
We have no price for Cross Country Healthcare since 28 July 2026. It may have been taken over, merged or renamed, so the figures below are from then.
$13.25+0.00% today
+6.0% since Oct 13, 25
1-year low $7.531-year high $13.25
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Cross Country Healthcare sold, what it kept, and what it did with the cash.
Sales went from $2.80 billion in 2022 to $1.05 billion in 2025, with -$94.9 million of profit last year.
SalesProfit
Cross Country Healthcare handed back 17% of the cash it generated last year.
Buybacks $7M
Free cash flow 2025$40M
Bought back its own shares$7M
Paid as dividends–
Cash vs. debt$109M vs. $2M
Cross Country Healthcare vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Cross Country Healthcare | No profit yet | ||
 Tenet Healthcare | 16.2× · Fair price | ||
 Solventum | 9.7× · Cheap | ||
 Encompass Health | 24.4× · Fair price | ||
 Fresenius Medical Care AG & Co. KGaA | 10.6× · Cheap |
AI analysis
An AI analyst reads Cross Country Healthcare's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 2,803 | 2,020 | 1,344 | 1,054 | |
| 624 | 450 | 274 | 214 | |
| 288 | 132 | 23 | -4 | |
| 280 | 129 | 4 | -65 | |
| 186 | 73 | -15 | -95 | |
| 5.02 | 2.05 | -0.44 | -2.93 | |
| 22.3% | 22.3% | 20.4% | 20.3% | |
| 10.3% | 6.5% | 1.7% | -0.4% | |
| 6.6% | 3.6% | -1.1% | -9.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 948 | 681 | 589 | 449 |
| Cash | 4 | 17 | 82 | 109 |
| Total debt | 158 | 5 | 4 | 2 |
| Total liabilities | 491 | 213 | 170 | 126 |
| 457 | 468 | 419 | 323 | |
| 38 | 35 | 33 | 32 | |
| 34.4% | 18.5% | -2.7% | -19.8% | |
| 40.7% | 15.5% | -3.5% | -29.4% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 134 | 248 | 120 | 48 | |
| 9 | 14 | 9 | 8 | |
| 125 | 235 | 111 | 40 | |
| Dividends paid | – | – | – | – |
| 35 | 58 | 37 | 7 | |
| 7 | 7 | 6 | 7 |
Valuation
- –
- 135.5×
- –
- 1.3×
- 0.4×
- 10.7×
- –
- 9.4%
- -22.2%
- 0.0%
Profitability
- 20.3%
- -0.4%
- -9.0%
- -6.7%
- -5.8%
- 7.9%
- -27.1%
- -21.9%
- -5.8%
- –
Growth
- −27.8%
- –
- −64.0%
- –
- −3.1%
Financial health
- -1.6×
- 0.01
- 0.5%
- -9.3×
- 3.29
- 3.29
- 2.22
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 31%of 946
Bottom 20%of 871
Bottom 4%of 867
Top 8%of 986
What analysts expect
- Average price target
- $10.61
- Range
- $8.65 – $14.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | -0.03 | -0.05 | +40.0% |
| Mar 4, 2026 | -0.06 | 0.03 | −300.0% |
| Nov 12, 2025 | 0.03 | 0.04 | −25.0% |
| Aug 6, 2025 | -0.01 | 0.07 | −114.3% |
| May 7, 2025 | 0.06 | 0.04 | +50.0% |
| Mar 5, 2025 | 0.04 | 0.11 | −63.6% |
| Nov 6, 2024 | 0.12 | 0.10 | +20.0% |
| Jul 31, 2024 | 0.10 | 0.14 | −28.6% |
News
Hf Foods signals 3- to 5-year cross-selling runway as Searay adds mid-teens EBITDA margin in first monthSeeking Alpha · Nov 10, 2026Check Point signals 2027 subscription revenue to cross $1.5B as it guides Q4 revenue to $720M-$770MSeeking Alpha · Nov 2, 2026Prediction: IonQ Will Cross $100 Per Share in 2027 (It's Less Than $40 Per Share Now)Yahoo Finance · Oct 15, 2026‘Other Mommy’ tops weekend box office with $27M, domestic ticket sales cross $8BSeeking Alpha · Oct 11, 2026Meta’s golden cross is back, and history likes what comes nextSeeking Alpha · Oct 7, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
62Pass
Philip Fisher
33No pass
Peter Lynch
29No pass
Joel Greenblatt
0No pass
Charlie Munger
35No pass
Terry Smith
21No pass
Questions about Cross Country Healthcare
Is Cross Country Healthcare a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Cross Country Healthcare AI analysis
What does Cross Country Healthcare do?
Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. It is in Medical - Care Facilities.
Does Cross Country Healthcare pay a dividend?
No. Cross Country Healthcare does not pay a dividend at the moment; in 2025 it returned $6.83 million to shareholders by buying back its own shares.
Is Cross Country Healthcare stock halal?
No. Cross Country Healthcare does not pass our halal screen: its cash and receivables are 67% of its market value, at or above the 49% limit. How we check
Who are Cross Country Healthcare's competitors?
The largest listed companies in the same industry are Tenet Healthcare, Solventum, Encompass Health and Fresenius Medical Care AG & Co. KGaA. The peers table on this page compares their profit, growth and price with Cross Country Healthcare's.
Prices: daily closes to Jul 28, 2026. Fundamentals: company reports via invest-like data.